Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05012254
Title Study of Nivolumab and Ipilimumab Plus Chemotherapy as a Treatment for Patients With Stage IV Lung Cancer With Brain Metastases (NIVIPI-Brain)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Fundacion GECP
Indications

lung non-small cell carcinoma

Therapies

Ipilimumab + Nivolumab

Carboplatin + Ipilimumab + Nivolumab + Paclitaxel

Cisplatin + Ipilimumab + Nivolumab + Pemetrexed Disodium

Carboplatin + Ipilimumab + Nivolumab + Pemetrexed Disodium

Age Groups: senior | adult
Covered Countries

Additional content available in CKB BOOST